Wolfe Research reiterates Peerperform on Cisco stock By Investing.com

Cisco reported Q3 sales of $15.84 billion, above the $15.54 billion consensus, and EPS of $1.06 versus $1.04 expected. July-quarter guidance also topped estimates at $16.8 billion in sales and $1.17 midpoint EPS, while the company pointed to nearly $68 billion of fiscal 2027 sales including about $6 billion of hyperscale AI revenue. Wolfe Research kept a Peerperform rating but flagged demand pull-forward and rich valuation, with the stock trading near its 52-week high at $101.87 and around 23x calendar 2028 EPS.

Analysis

The market is treating this as a clean AI/infrastructure acceleration story, but the more interesting signal is that Cisco’s near-term strength may be partially non-recurring. When customers pull orders forward ahead of pricing actions and component tightness, reported demand gets mechanically inflated, which can leave a softer gap two to three quarters later once the procurement wave normalizes. That makes the current setup more of a digestion trade than a straight-line re-rating, especially with the stock already discounting a premium multiple versus its own history.

Second-order winners are likely in the optoelectronics and networking supply chain rather than CSCO itself. If webscale and AI buildouts remain intact, suppliers with tighter exposure to transceiver, optical interconnect, and custom silicon content should see better incremental margin leverage than the system vendor, because they capture the mix shift without bearing as much pricing pressure. Conversely, enterprise networking peers with less AI relevance could face a tougher comparison as Cisco’s narrative crowds out budget allocation and raises expectations across the group.

The key risk to the bullish thesis is timing: the AI revenue ramp is real, but the cash flow impact may be back-end loaded into FY26-FY27 while the stock is already near the highs. If hyperscaler buying pauses even briefly, the multiple can compress faster than consensus models can reset, because the market is currently paying for execution certainty rather than merely growth. The contrarian read is that this is a quality franchise with improving fundamentals, but the opportunity may be in buying any post-earnings consolidation rather than chasing strength after a guidance beat.

For the next 1-4 weeks, the path of least resistance may still be up, but over 3-6 months the setup looks vulnerable to a valuation mean reversion if order momentum decelerates. That makes the trade less about questioning the business and more about whether the current price has already capitalized the next 12-18 months of AI upside.

Key Decisions for Investors

• Trim/hedge CSCO into strength; use call spreads or replace outright long with a partial collar over the next 2-4 weeks to protect against a post-earnings multiple reset.
• If long CSCO, wait for a 5-8% pullback or a 2-3 week consolidation before adding; risk/reward is materially better once the market digests the forward-pull-forward risk.
• Pair trade: long AVGO or COHR vs short CSCO over 1-3 months to express AI-networking exposure with better leverage to optical/content intensity and less reliance on legacy enterprise demand.
• Buy downside protection on CSCO via 3-6 month puts or put spreads if shares remain within 3% of highs; the premium cost is justified by valuation compression risk if hyperscaler orders normalize.
• Tactically overweight the supply chain rather than the prime contractor: favor optic/transceiver names on any AI capex confirmation, as they should capture higher incremental margin than CSCO over the next 2-4 quarters.